Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Share Options

16 Mar 2018 07:00

RNS Number : 9200H
Falanx Group Limited
16 March 2018
 

Falanx Group Limited

("Falanx" or "the Company")

Grant of Share Options

Falanx Group Ltd announces the grant of 15,000,000 share options to the Directors and 9,150,000 share options to other management and employees (together the "Share Options").

The Company considers it important to incentivise employees and Directors through share incentive arrangements and to align them with shareholders to create long term value.

Options under this plan are granted with a strike price of 5p each, this is approximately 11% higher than the mid-market closing price of 4.5p on 15 March 2018. The option scheme is structured so that there are only returns for participants where the share price has very significantly increased from the current levels. Individual Director grants are set out below:

Individual Director Option Grants

 

Current Share Options

New Grant

Enlarged Share Options

Mike Read

-

5,000,000

5,000,000

Ian Selby

-

5,000,000

5,000,000

John Blamire

500,000

4,500,000

5,000,000

Emma Shaw

750,000

500,000

1,250,000

 

Vesting Criteria

These options vest in three tranches: the first tranche when the share price reaches 7.5p (25%), the second tranche when the share price reaches 10p (25%) and the third tranche when the share price reaches 12.5p (50%). The Share Options only vest if the average share price has reached the relevant threshold level for a period of three months, save for the event of a change of control in the Company, in which case they will vest in full. Based on the mid-market closing price of 4.5p, there is no gain at all unless the share price increases by 66% and full gains are not achieved until a gain of 178% has been achieved.

A further option grant is planned soon for staff in the recently acquired First Base business.

Executive Directors are issued share options under the EMI Scheme and Non-Executive Directors and (any other ineligible participants) under an unapproved scheme, which has the same rules as the EMI Scheme but without the relevant tax concessions. The Share Options have an exercise period of 10 years from grant under the rules of the EMI Scheme.

The above grant of 24,150,000 options represents approximately 9% of the share capital following the admission of the shares announced on 6 March 2018.

   

 

Falanx Group Limited

Mike Read, Chairman and CEO

John Blamire, COO

Ian Selby, CFO

 

www.falanx.com

 

 

SPARK Advisory Partners Limited

Nominated Adviser

Matt Davis / James Keeshan

+44 (0) 203 368 3551

 

 

 

 

 

Turner Pope Investments (TPI) Ltd

Broker

Andy Thacker

 

IFC Advisory Ltd

Financial PR & IR

Graham Herring

Miles Nolan

Zach Cohen

+44 (0) 203 621 4120

 

 

 

+44 (0) 203 934 6630

     

 

Falanx Group Limited, is a global intelligence and cyber defence provider working with blue chip and government clients. The Group listed on AIM in June 2013 under ticker FLX For more information: http://www.falanx.com/ 

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1. Mike Read

2. Ian Selby

3. John Blamire

4. Emma Shaw

2

Reason for the notification

a)

Position/status

Directors and PDMRs of the Company

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Falanx Group Limited

b)

LEI

213800YO4F9CUQLALV19

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Options over Ordinary Shares

 

 

 

ISIN: VGG3338A1075

b)

Nature of the transaction

Grant of nil-cost options

 

c)

Price(s) and volume(s)

 

Price: 5p

Volume

1. 5,000,000

2. 5,000,000

3. 4,500,000

4. 500,000

 

5.

d)

Aggregated information

 

- volume: 15,000,000

- Price: 5p

e)

Date of the transaction

15 March 20018

f)

Place of the transaction

Not on a trading venue

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHFKPDNNBKBKND
Date   Source Headline
4th May 201712:02 pmRNSDirector / PDMR Shareholding
4th May 201712:02 pmRNSResults of the Placing and Total Voting Rights
4th May 20177:02 amRNSProposed Placing to raise up to £2 million
4th May 20177:00 amRNSTrading Update
18th Apr 201712:15 pmRNSChange of Website Address
28th Mar 20177:00 amRNSProprietary Platform and Partnership Agreements
8th Mar 20177:00 amRNSAppointment of Chief Finance Officer
13th Feb 20177:00 amRNSNew Business Unit - Falanx Cyber Technologies
30th Jan 20177:02 amRNSDirectorate Change
30th Jan 20177:01 amRNSOperational Update
30th Jan 20177:00 amRNSChange of Adviser
25th Jan 20177:00 amRNSDirector/PDMR Shareholding
11th Jan 20179:00 amRNSIssue of Equity
20th Dec 20161:49 pmRNSDirector/PDMR Shareholding
15th Dec 20167:00 amRNSAGM Statement
25th Nov 20165:11 pmRNSIssue of Equity
16th Nov 20165:55 pmRNSNotice of AGM
9th Nov 20163:20 pmRNSAdditional Listing
1st Nov 20167:01 amRNSInterim Results
1st Nov 20167:00 amRNSDirectorate Change
26th Oct 20169:53 amRNSHolding(s) in Company
19th Oct 201611:07 amRNSHolding(s) in Company
17th Oct 20167:00 amRNSDirectorate Change, Trading Update, Notice of Rsts
3rd Oct 20167:00 amRNSPlacing and Early Redemption of Loan Note
18th Jul 20167:00 amRNSPreliminary Results
20th Jun 20167:00 amRNSDirectorate Change
11th May 201610:14 amRNSIssue of Equity and Directors' Dealings
11th May 20167:00 amRNSTrading Update and New Cyber Security Contract Win
5th May 20167:00 amRNSAcquisition, Placing and issue of Loan Notes
21st Mar 20167:00 amRNSContract win
2nd Feb 20167:00 amRNSAppointment of Non-Executive Chairman
23rd Dec 20153:15 pmRNSDirector Dealing
21st Dec 20157:00 amRNSSignificant contract win
9th Nov 20157:00 amRNSInterim Results
6th Nov 20158:49 amRNSDirectorate Change
26th Oct 20157:00 amRNSNotice of Results
15th Oct 20157:00 amRNSChange of Adviser
24th Sep 20157:00 amRNSOperational Update
15th Jul 20157:00 amRNSPreliminary Results
6th Jul 201510:21 amRNSNotice of Results
21st May 20152:33 pmRNSHolding(s) in Company
18th May 201510:56 amRNSHolding(s) in Company
15th May 201511:11 amRNSHolding(s) in Company
8th May 20157:00 amRNS£2.64 million placing
18th Mar 20157:00 amRNSFalanx Cyber Update
2nd Mar 20157:00 amRNSCyber Insurance Joint Venture
2nd Feb 20157:00 amRNSUK Government Framework Agreement
31st Dec 20147:00 amRNSTotal Voting Rights
22nd Dec 20147:00 amRNSInterim Results
1st Dec 20147:00 amRNSExercise of Warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.